Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Thrombosis Research

• Publication date

  1982-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0049-3848(82)90095-0PMID 6762683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adenosinediphosphate induced platelet adhesiveness in diabetes mellitus with complications.

  2009cited by this paper
• Editorial

  1984cited by this paper
• Increased platelet thromboxane synthesis in diabetes mellitus.

  1981cited by this paper
• Hematologic alterations in diabetes mellitus.

  1981cited by this paper
• Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus.

  1980cited by this paper
• Effect of cholesterol on production of thromboxane b2 by platelets in vitro.

  1980cited by this paper
• Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats.

  1980cited by this paper
• Continuous Subcutaneous Infusion of Insulin in the Management of Diabetes Mellitus

  1980cited by this paper
• Synthesis of thromboxane B2 and 6-keto-prostaglandin F1 alpha by bovine gastric mucosal and muscle microsomes.

  1980cited by this paper
• CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: IMPROVED BLOOD-GLUCOSE AND INTERMEDIARY-METABOLITE CONTROL IN DIABETICS

  1979cited by this paper
• Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump.

  1979cited by this paper
• Changes of Platelet Function and Blood Clotting in Diabetes Mellitus

  1979cited by this paper
• Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes.

  1979cited by this paper
• Decreased vascular prostacyclin in juvenile-onset diabetes.

  1979cited by this paper
• Platelet survival in diabetes mellitus using an aspirin-labelling technique.

  1979cited by this paper
• Coexistence of deficiency in alpha1 antitrypsin and in growth hormone.

  1979cited by this paper
• Increased biosynthesis of thromboxane A2 by diabetic platelets

  1979cited by this paper
• Platelet function and diabetes mellitus.

  1978cited by this paper
• Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.

  1977cited by this paper
• Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187.

  1977cited by this paper
• Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with an without vascular disease.

  1977cited by this paper
• Determination of platelet and fibrinogen half-life with [75Se]selenomethionine: studies in normal and in diabetic subjects.

  1975cited by this paper
• Platelet abnormalities in diabetic peripheral neuropathy.

  1975cited by this paper
• Increased platelet aggregation in early diabetus mellitus.

  1975cited by this paper
• Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.

  1974cited by this paper
• Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.

  1974cited by this paper
• The increased percentage of megathrombocytes in various clinical disorders.

  1972cited by this paper
• Increased platelet aggregation in diabetes mellitus.

  1972cited by this paper
• Platelet adhesiveness and aggregation in relation to diabetic retinopathy

  1971cited by this paper
• Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus.

  1970cited by this paper
• Platelets, Coagulation and Fibrinolysis in Diabetic and Non-Diabetic Patients with Quiescent Coronary Heart Disease

  1970cited by this paper
• TEN YEARS' EXPERIENCE OF STEROID ASSAYS IN THE MANAGEMENT OF BREAST CANCER

  1968cited by this paper
• Platelet adhesiveness in diabetes mellitus

  1967cited by this paper
• INCREASED ACTIVIY OF "ANTI-WILLEBRAND FACTOR" IN DIABETIC PLASMA.

  1964cited by this paper
• Increased Activity of “Anti-Willebrand Factor” in Diabetic Plasma

  1964cited by this paper

• Overview of Platelet Physiology: Its Hemostatic and Nonhemostatic Role in Disease Pathogenesis

  2014cites this paper
• Platelet Cd Markers By Flow Cytometry In Normal Individuals And In Patients With Untreated Type 2 Diabetes Mellitus

  2013cites this paper
• Cochrane review: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus

  2010cites this paper
• Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.

  2010cites this paper
• Role of Electro-Diagnostic Tests In Early Detection of Diabetic Neuropathy

  2009cites this paper
• Thrombozytenfunktion bei Diabetes mellitus

  2008cites this paper
• PLATELET FUNCTION IN DIABETES MELLITUS

  2005cites this paper
• Improved glycemic control and platelet function abnormalities in diabetic patients with microvascular disease.

  2000cites this paper
• Essential Fatty Acids and Prostaglandins in Pregnancy

  1998cites this paper
• Aspirin therapy in diabetic subjects post-myocardial infarction.

  1997cites this paper
• Platelet Aggregation in Type 1 Diabetes without Microvascular Disease During Continuous Subcutaneous Insulin Infusion

  1996cites this paper
• Hemostatic factors as triggers of cardiovascular events.

  1996cites this paper
• Retinal blood flow increases following short-term aspirin usage in type I diabetics with no or minimal retinopathy.

  1996cites this paper
• Hemostatic risk factors for cardiovascular disease

  1996cites this paper
• Platelet aggregation in type 1 diabetes without microvascular disease during continuous subcutaneous insulin infusion.

  1996cites this paper
• Hemostatic concomitants of syndrome X.

  1995cites this paper
• Insulin increases the aggregation response of human platelets to ADP.

  1994cites this paper
• 10 Myeloproliferative and metabolic causes

  1994cites this paper
• The inhibitory effect of platelets on fibrinolysis in diabetic patients.

  1994cites this paper
• Myeloproliferative and metabolic causes.

  1994cites this paper
• The In Vitro Production of Thromboxane B2 by Platelets of Diabetic Patients Is Normal at Physiological Concentrations of lonized Calcium

  1993cites this paper
• Platelet hyperreactivity and vasculopathy in insulin dependent diabetes mellitus.

  1992cites this paper
• Altered Platelet Function in Diabetes Mellitus: Effect of Glycemic Regulation and Antiplatelet Agents

  1992cites this paper
• Platelet function in diabetes mellitus.

  1992cites this paper
• Seminars in thrombosis, thrombolysis, and vascular biology. 6. Procoagulant states.

  1992cites this paper
• Prostaglandins in Pregnancy

  1991cites this paper
• Vitamin E and platelet eicosanoids in diabetes mellitus.

  1990cites this paper
• Comparative efficacy of dietary treatments on renal function in rats with sub-total nephrectomy: renal polyunsaturated fatty acid incorporation and prostaglandin excretion.

  1990cites this paper
• Acquired disorders of platelet function.

  1989cites this paper
• 10 Acquired disorders of platelet function

  1989cites this paper
• Antithrombin III activity, von Willebrand factor antigen and platelet function in young diabetic patients treated with multiple insulin injections versus insulin pump treatment

  1989cites this paper
• Altered membrane fatty acid composition and increased thromboxane A2 generation in platelets from patients with diabetes.

  1989cites this paper
• Antithrombin III activity, von Willebrand factor antigen and platelet function in young diabetic patients treated with multiple insulin injections versus insulin pump treatment

  1989cites this paper
• Platelet Aggregation and Nutritional Status in Insulin Dependent Diabetes mellitus

  1989cites this paper
• Effects of chronic fetal hyperinsulinemia on plasma arachidonic acid and prostaglandin concentrations.

  1989cites this paper
• Effect of Vitamin E Supplementation on Platelet Thromboxane A2 Production in Type I Diabetic Patients: Double-Blind Crossover Trial

  1988cites this paper
• Diurnal variation in platelet aggregation responses.

  1988cites this paper
• Platelet function in type I diabetes mellitus.

  1988cites this paper
• Reduction of platelet aggregation induced by euglycaemic insulin clamp

  1987influential citation
• Alloxan-induced hyperglycemia in rabbits and the response of platelets to aggregating agents in vitro and to exposed subendothelium in vivo.

  1987cites this paper
• Plasma lipid fatty acids and platelet function during continuous subcutaneous insulin infusion in type I diabetes.

  1987cites this paper
• The effects of a thromboxane synthase inhibitor, a prostacyclin analog and PGE1 on the nephritis of the NZB/W F1 mouse.

  1987cites this paper
• Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.

  1987cites this paper
• Nutrition and platelet function in atherogenesis

  1987cites this paper
• Diabetes mellitus, vascular disease and thrombosis.

  1986cites this paper
• Ginger: inhibition of thromboxane synthetase and stimulation of prostacyclin: relevance for medicine and psychiatry.

  1986cites this paper
• Improvement of diabetic control by continuous subcutaneous insulin infusion therapy changes fatty acid composition of serum lipids and erythrocytes in Type 1 (insulin-dependent) diabetes

  1986cites this paper
• Factors of the hemostatic system in diabetic patients. A survey of controlled studies.

  1986cites this paper
• Platelet Behaviour in Non-Insulin-Dependent Diabetes -Influence of Vascular Complications, Treatment and Metabolic Control

  1986cites this paper
• Thromboxane production in diabetes mellitus

  1986cites this paper
• Detection of Prethrombotic States in Patients with Atherosclerotic Lesions

  1986cites this paper
• Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic pregnancies.

  1985cites this paper
• Insulin and arachidonic acid metabolism in diabetes mellitus.

  1985cites this paper
• Platelet function and thrombus in diabetes.

  1985cites this paper
• 14 – Platelet Involvement in Diabetes Mellitus

  1985cites this paper
• Hemostasis disorders in diabetes mellitus.

  1985cites this paper
• Platelet Function During Continuous Insulin Infusion Treatment in Insulin-dependent Diabetic Patients

  1985cites this paper
• Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.

  1985cites this paper
• Pathogenesis of atherosclerosis.

  1985cites this paper
• Improved diabetic control and platelet reactivity.

  1985cites this paper
• Near-normal glycaemic control does not correct abnormal platelet reactivity in diabetes mellitus.

  1984cites this paper
• Fibrin generation during the diabetic pregnancy

  1984cites this paper
• Platelets and diabetic vascular disease.

  1983cites this paper
• New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.

  1983cites this paper
• PLATELET FUNCTION IN DIABETES MELLITUS

  1980cites this paper
• Platelets and diabetes mellitus.

  1977cites this paper